SCHEMBL4334130

SCHEMBL4334130

COc1ccc(NC(=O)OCCc2cccc(CC(C(=O)O)C(=O)O)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
TP53 P04637 2/20 0.56
FPR2 P25090 1/20 0.52
LDHA P00338 1/20 0.50
MGLL Q99685 1/20 0.49
MTNR1B P49286 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.45
NPC1 O15118 1/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.44
ROCK2 O75116 1/20 0.44
CNR1 P21554 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810370 0.93 LMNA (0.53) LMNATP53FPR2MGLLMTNR1B
SCHEMBL4337094 0.90 MGLL (0.54) LMNATP53MGLLMTNR1BSMN1; SMN2
SCHEMBL4333325 0.88 FPR2 (0.54) LMNATP53FPR2LDHAMGLL
SCHEMBL4328095 0.88 MGLL (0.51) LMNATP53MGLLMTNR1BSMN1; SMN2
SCHEMBL4339388 0.88 MGLL (0.62) LMNATP53MGLLSMN1; SMN2RAB9A
SCHEMBL4341184 0.87 LMNA (0.50) LMNATP53FPR2MGLLMTNR1B
SCHEMBL4336497 0.87 PPARG (0.52) LMNATP53FPR2MGLLMTNR1B
SCHEMBL4336950 0.86 MGLL (0.51) MGLLSMN1; SMN2RAB9ANPC1RECQL
SCHEMBL13810359 0.85 MGLL (0.58) LMNATP53MGLLSMN1; SMN2RAB9A
SCHEMBL4331833 0.84 LDHA (0.50) LMNATP53FPR2LDHASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 LMNA 3790/4885TP53 4574/4885FPR2 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.